9,745 results
-
Plasmid#168532PurposeGateway-compatible Entry vectorDepositorInsertS (S )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 ORF3a_nostop
Plasmid#168533PurposeGateway-compatible Entry vectorDepositorInsertORF3a (ORF3a )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 ORF3b_nostop
Plasmid#168534PurposeGateway-compatible Entry vectorDepositorInsertORF3b (ORF3b )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 N_nostop
Plasmid#168542PurposeGateway-compatible Entry vectorDepositorInsertN (ORF9a) (N )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 NSP2_stop
Plasmid#168545PurposeGateway-compatible Entry vectorDepositorInsertNSP2 (ORF1ab )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 NSP4_stop
Plasmid#168546PurposeGateway-compatible Entry vectorDepositorInsertNSP4 (ORF1ab )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 NSP13_stop
Plasmid#168554PurposeGateway-compatible Entry vectorDepositorInsertNSP13 (ORF1ab )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 NSP1_nostop
Plasmid#168518PurposeGateway-compatible Entry vectorDepositorInsertNSP1 (ORF1ab )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 NSP2_nostop
Plasmid#168519PurposeGateway-compatible Entry vectorDepositorInsertNSP2 (ORF1ab )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 NSP6_nostop
Plasmid#168522PurposeGateway-compatible Entry vectorDepositorInsertNSP6 (ORF1ab )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDONR223 SARS-CoV-1 NSP13_nostop
Plasmid#168528PurposeGateway-compatible Entry vectorDepositorInsertNSP13 (ORF1ab )
UseOtherAvailable SinceJan. 20, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-3JB1R+4
Plasmid#190841PurposeFor mammalian expression of 3JB1R+4, a dual-specificity aptamer that binds OGT and GFP. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a folded linker.DepositorInsert3JB1R_AP3+4bp (A Dual-Specificity aptamer targeting OGT and GFP)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-3JB1R+8
Plasmid#190843PurposeFor mammalian expression of 3JB1R+8, a dual-specificity aptamer that binds OGT and GFP. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a folded linker.DepositorInsert3JB1R_AP3+8bp (A Dual-Specificity aptamer targeting OGT and GFP)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-3JB1R+10
Plasmid#190844PurposeFor mammalian expression of 3JB1R+10, a dual-specificity aptamer that binds OGT and GFP. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a folded linker.DepositorInsert3JB1R_AP3+10bp (A Dual-Specificity aptamer targeting OGT and GFP)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-3JB1R+12
Plasmid#190845PurposeFor mammalian expression of 3JB1R+12, a dual-specificity aptamer that binds OGT and GFP. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a folded linker.DepositorInsert3JB1R_AP3+12bp (A Dual-Specificity aptamer targeting OGT and GFP)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-4JC1FF
Plasmid#190846PurposeFor mammalian expression of 4JC1FF, a dual-specificity aptamer that binds OGT and GFP. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a folded linker.DepositorInsert4JC1FF (A Dual-Specificity aptamer targeting OGT and GFP)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-T1-U6-bc339
Plasmid#190849PurposeFor mammalian expression of T1 and bc339, the RNA aptamers of ncOGT and β-catenin, respectively. Expression of each aptamer is driven by a U6 promoter.DepositorInsertsT1 (an RNA aptamer of O-GlcNAc Transferase)
bc339 (an RNA aptamer of β-catenin)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-NL8F50
Plasmid#190850PurposeFor mammalian expression of NL8F50, a dual-specificity aptamer that binds OGT and β-catenin. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a flexible linker.DepositorInsertNL8F50 (A Dual-Specificity aptamer targeting OGT and β-catenin)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-NL8F70
Plasmid#190851PurposeFor mammalian expression of NL8F70, a dual-specificity aptamer that binds OGT and β-catenin. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a flexible linker.DepositorInsertNL8F70 (A Dual-Specificity aptamer targeting OGT and β-catenin)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
pSilencer2.1-U6-3JB8F+4
Plasmid#190853PurposeFor mammalian expression of 3JB8F+4, a dual-specificity aptamer that binds OGT and β-catenin. Expression is driven by a U6 promoter. This dual-specificity aptamer adopts a folded linker.DepositorInsert3JB8F_T1+4bp (A Dual-Specificity aptamer targeting OGT and β-catenin)
UseAffinity Reagent/ Antibody and Synthetic BiologyExpressionMammalianPromoterU6Available SinceJan. 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits